Cholesterol-tetraethylene glycol CE-phosphoramidite
Phosphoramidite for the incorporation of cholesterol at the 5' end of an oligonucleotide, with a tetraethylene glycol spacer.
Phosphoramidite for the incorporation of cholesterol at the 5' end of an oligonucleotide, with a tetraethylene glycol spacer.
Phosphoramidite used to incorporate a 5' biotin functionality, separated from the oligonucleotide by a photo-cleavable linker.
Phosphoramidite used to incorporate a 5-hydroxy-modified deoxyuridine into an oligonucleotide for epigenetic studies.
Phosphoramidite used to incorporate a ferrocene-modified deoxythymidine into an oligonucleotide.
Phosphoramidite used to incorporate a tocopherol modification at the 5' end of an oligonucleotide, with a C8 spacer.
Phosphoramidite used to incorporate a 5-formyl-modified deoxycytidine into an oligonucleotide for epigenetic studies.
Phosphoramidite used to incorporate a fluoro-modified deoxyuridine internally or at the 5' end of an oligonucleotide.
Phosphoramidite for incorporation of cholesterol at 5' end of an oligonucleotide, with a triethylene glycol spacer.
Phosphoramidite for incorporation of Biotin with a dT nucleobases, internally or at the 5' end of an oligonucleotide.
Phosphoramidite used to incorporate a bromo-modified uridine internally or at the 5' end of an oligonucleotide.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |